Want to see HK:1715 full AI Analyst Report?
Top Page
Miji International Holdings Limited
(1715)
Select Model
Select Model
Rating:45Neutral
Price Target:
HK$0.40
▼(-19.39% Downside)
Action:Reiterated
Date:08/17/26
The score is held down primarily by weak financial performance (persistent losses, margin deterioration, revenue decline, and ongoing cash burn), only partially offset by improving leverage and reduced cash outflow versus 2024. Technicals are neutral with mild short-term momentum but a weaker longer-term trend, while valuation is constrained by a negative P/E that reflects loss-making operations.
Positive Factors
Improved leverage
The lower debt-to-equity ratio is a constructive balance-sheet change that can reduce financing pressure and improve resilience. Although leverage remains material and losses still constrain flexibility, this improvement provides a stronger base if operating performance stabilizes.
Negative Factors
Persistent losses and margin deterioration
Sustained losses and a sharply negative net margin show that the business is not currently converting operations into profits. The deterioration from earlier gross-margin levels suggests weak operating leverage and raises concern that the model remains unprofitable at its current scale.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved leverage
The lower debt-to-equity ratio is a constructive balance-sheet change that can reduce financing pressure and improve resilience. Although leverage remains material and losses still constrain flexibility, this improvement provides a stronger base if operating performance stabilizes.
Read all positive factors
Miji International Holdings Limited (1715) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$146.11M
Dividend YieldN/A
Average Volume (3M)533.77K
Price to Earnings (P/E)―
Beta (1Y)-0.20
Revenue Growth15.42%
EPS Growth29.14%
CountryHK
Employees52
SectorConsumer Cyclical
Sector Strength84
IndustryFurnishings, Fixtures & Appliances
Share Statistics
EPS (TTM)-0.11
Shares Outstanding360,759,900
10 Day Avg. Volume431,680
30 Day Avg. Volume533,773
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.99
Price to Sales (P/S)2.46
P/FCF Ratio-9.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Miji International Holdings Limited Business Overview & Revenue Model
Company Description
AI Health Technology Limited, an investment holding company, engages in the research and development, manufacturing, and trading of kitchen appliances primarily in the People’s Republic of China. It provides radiant and induction hobs and stoves, ...
Miji International Holdings Limited Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.44M | 47.40M | 91.89M | 84.37M | 88.19M | 143.87M |
| Gross Profit | 4.40M | 4.26M | 6.49M | 21.22M | 38.49M | 65.27M |
| EBITDA | -37.98M | -29.35M | -28.31M | -36.05M | -30.94M | -35.40M |
| Net Income | -43.52M | -35.56M | -35.85M | -49.32M | -43.21M | -44.35M |
Balance Sheet | ||||||
| Total Assets | 103.86M | 146.75M | 137.47M | 165.74M | 193.80M | 190.72M |
| Cash, Cash Equivalents and Short-Term Investments | 50.51M | 27.09M | 2.30M | 33.95M | 11.36M | 32.35M |
| Total Debt | 39.50M | 46.22M | 60.74M | 71.40M | 79.92M | 32.92M |
| Total Liabilities | 64.36M | 87.06M | 95.08M | 107.53M | 113.90M | 66.58M |
| Stockholders Equity | 38.65M | 58.83M | 42.06M | 58.21M | 80.36M | 124.27M |
Cash Flow | ||||||
| Free Cash Flow | -11.15M | -12.47M | -35.37M | 13.80M | -76.70M | -13.24M |
| Operating Cash Flow | -11.15M | -12.47M | -35.21M | 14.42M | -75.93M | -11.02M |
| Investing Cash Flow | 0.00 | 423.00K | -101.00K | -2.00K | 15.03M | 6.67M |
| Financing Cash Flow | -6.84M | 34.51M | 3.63M | 8.13M | 39.30M | -10.74M |
Miji International Holdings Limited Technical Analysis
Negative
0.49
Price Trends
0.44
Negative
0.46
Negative
0.47
Negative
Market Momentum
-0.01
Positive
33.56
Neutral
20.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1715, the sentiment is Negative. The current price of 0.49 is above the 20-day moving average (MA) of 0.45, above the 50-day MA of 0.44, and above the 200-day MA of 0.47, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 33.56 is Neutral, neither overbought nor oversold. The STOCH value of 20.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1715.
Miji International Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$757.05B | 14.50 | 19.96% | 4.95% | 9.41% | 6.11% | |
73 Outperform | HK$211.43B | 10.72 | 14.77% | 6.41% | 0.59% | -6.14% | |
63 Neutral | HK$470.41M | 10.54 | 5.15% | 6.77% | -8.88% | -4.52% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$411.09M | 120.59 | 0.51% | 4.88% | -3.83% | -93.40% | |
56 Neutral | HK$5.17B | 14.93 | 8.56% | 3.47% | 0.39% | ― | |
45 Neutral | HK$146.11M | -3.01 | -89.30% | ― | 15.42% | 29.14% |
* Consumer Cyclical Sector Average
HK:1715
Miji International Holdings Limited
0.41
0.09
26.56%
HK:1373
International Housewares Retail Co
0.67
-0.13
-15.93%
HK:0229
Raymond Industrial Limited
0.82
-0.08
-8.58%
HK:1691
JS Global Lifestyle Company Limited
1.51
-0.35
-18.82%
HK:6690
Haier Smart Home Co., Ltd. Class H
20.58
-3.48
-14.47%
HK:0300
Midea Group Co. Ltd. Class H
99.20
18.19
22.46%
Miji International Holdings Limited Corporate Events
AI Health Technology Corrects Substantial Shareholder Disclosure in Interim Results
Aug 27, 2026
AI Health Technology Limited has issued a supplemental announcement to its interim results for the six months ended 30 June 2026 to correct information on substantial shareholders’ interests. The company clarified that, as of that date, Star...
AI Health Technology Widens Interim Loss Despite Revenue Growth
Aug 26, 2026
AI Health Technology Limited reported a sharp increase in interim revenue to RMB42.97 million for the six months ended 30 June 2026, up from RMB23.94 million a year earlier. However, gross profit margins compressed from 10.0% to 5.9%, reflecting h...
AI Health Technology Warns of Wider Interim Loss on Higher Investment Costs
Aug 12, 2026
AI Health Technology Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates health-related businesses supported by technology and is developing a comprehensive marketing solution system. The group has been...
AI Health Technology Sets Board Meeting to Review Interim Results and Dividend
Aug 12, 2026
AI Health Technology Limited has scheduled a board meeting for 26 August 2026 to review and approve the unaudited consolidated interim results for the six months ended 30 June 2026. The board will also decide on the publication of these results an...
AI Health Technology Sets Up Investment Committee to Strengthen Governance
Jul 29, 2026
AI Health Technology Limited has formed a new investment committee, effective 29 July 2026, to oversee and handle matters related to the company’s investment activities. The committee is designed to centralise decision-making on investments,...
AI Health Technology Sets Out Board and Committee Structure
Jul 29, 2026
AI Health Technology Limited, incorporated in the Cayman Islands and listed in Hong Kong under stock code 1715, operates in the health technology sector. The company is overseen by a Board comprising executive and independent non-executive directo...
AI Health Technology Forms Board Investment Committee to Oversee Surplus Funds
Jul 29, 2026
AI Health Technology Limited has established an investment committee of its board to oversee the management and investment of surplus and designated funds within the group. The committee will be composed of at least three members drawn from direct...
AI Health Technology Sets Out Board and Committee Structure
Jul 2, 2026
AI Health Technology Limited has detailed the composition of its board of directors and clarified the roles of its executive and independent non-executive members. The structure underscores a standard governance framework aimed at balancing manage...
AI Health Technology appoints Wang Jian as new executive director
Jul 2, 2026
AI Health Technology Limited has appointed Ms. Wang Jian as an executive director with effect from 2 July 2026, adding a seasoned manager with extensive experience in architectural design, construction engineering, cultural creativity, and health-...
AI Health Technology Sets Out Board and Committee Structure
Jun 26, 2026
AI Health Technology Limited has announced the current composition of its board of directors, naming Zhao Jie as chairman and Maeck Can Yue as chief executive officer, supported by independent non-executive directors Shen Shujing, Lin Dongming and...
AI Health Technology Wins Full Shareholder Backing for AGM Resolutions and New Auditor
Jun 26, 2026
AI Health Technology Limited reported that all resolutions tabled at its annual general meeting on 26 June 2026 were approved by shareholders via poll, including adoption of the 2025 financial statements and confirmation of board remuneration. Sha...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.